An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis Suppurativa: our experience

Over recent years, the link between obesity, metabolic syndrome and Hidradenitis Suppurativa (HS) has been explored. It has been demonstrated that HS patients have a high prevalence of the metabolic syndrome and an increased frequency of insulin resistance. The objective of our study is to estimate the effectiveness of an oral supplementation based on myo- inositol (MI), folic acid and liposomal magnesium (LEVIGON®) on the clinical and metabolic profile of patients affected by HS.